AI is transforming clinical development, but what happens when usage costs spike? Jon Newton explains how to govern it before the bill lands.
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Taking eCOA Technology Deployment Off The Critical Path
Consider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.
-
CRO Uses CRIO eSource To Double Monitoring Productivity
Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.
-
AI In Clinical Trials: Key Insights From Industry Experts
Find out what experts from the FDA are saying about AI’s ability to demonstrably impact three critical success metrics in clinical trials.
-
Implementing eSource: A Guide For Operations And Technology Roles
By recognizing and addressing the challenges associated with eSource integration, research facilities can fully harness its transformative potential, optimizing efficiency and reliability.
-
Empowering Caregivers With ePRO Technology For Cancer Support
Explore the importance of involving caregivers in the care process and how electronic patient-reported outcomes technology can facilitate communication, tracking, and collaboration.
-
Key CTMS Capabilities To Improve Financial Management
In clinical research, utilizing your clinical trial management system (CTMS) to its fullest potential can allow for more streamlined financial management, visit management, compliance, patient recruitment, and more. This blog outlines what you should look for in a CTMS to maximize your organization’s return on investment (ROI).
-
What 9 Years Of MDR Experience Is Changing About PMCF Planning
Re-evaluate your compliance roadmap by exploring expert perspectives on navigating regulatory shifts, distinguishing core surveillance obligations, and building a defensible, value-driven clinical data strategy.
-
Reduce Time, Cost, & Risk With Clinical Study Data Review Software
See how a top 10 global biopharmaceutical company implemented a single data review system to reduce the time, cost, and risk of running its clinical trials while accelerating the time to market.
-
SMART On FHIR: Auto-Populate eCRFs On Study Day 1
Get an overview of SMART on Fast Healthcare Interoperability (FHIR) for clinical trials, including workflow improvements, real-world data (RWD) integration, and reducing researcher burnout.
-
Your CRAs Aren't Monitoring. They're Managing Workarounds.
CRA productivity rises when monitoring shifts from manual tasks to streamlined access, standardized workflows, and proactive oversight — freeing time for engagement, data quality, and patient safety.
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
RECENT NEWSLETTERS
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives